Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis
In P2Y<sub>12</sub>-naïve STEMI patients undergoing primary PCI, no significant differences were noted in the risk of in-hospital ischemic and bleeding events between downstream cangrelor and upstream ticagrelor.
Authors
- Antonio Greco (ORCID: https://orcid.org/0000-0002-4824-9871)
- Piera Capranzano (ORCID: https://orcid.org/0000-0001-8434-7367)
- Sofia Sammartino (ORCID: https://orcid.org/0009-0002-4985-1327)
- Claudio Laudani (ORCID: https://orcid.org/0000-0001-5467-7402)
- Lorenzo Scalia (ORCID: https://orcid.org/0009-0006-8429-1619)
- Marco Spagnolo (ORCID: https://orcid.org/0000-0002-5434-607X)
- Maria Sara Mauro (ORCID: https://orcid.org/0000-0001-9432-9314)
- Davide Capodanno (ORCID: https://orcid.org/0000-0002-5156-7723)
Institutions
- University of Catania (IT)
- Policlinico Universitario di Catania (IT)
- Ospedali Riuniti Umberto I (IT)
Publication Details
- Journal
- International Journal of Cardiology
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.ijcard.2024.132660
- Citations
- 5
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.01